Program Overview

Accreditation Information

In the United States, breast cancer is the most common cancer (excluding skin cancer) among women. Approximately 250,000 cases of invasive breast cancer are diagnosed each year, with about 40,000 breast cancer deaths. Results from numerous clinical trials continue to expand diagnostic and prognostic tools, therapeutic options, and supportive care strategies. It is important for health care professionals to remain up-to-date on current and emerging scientific data to make evidence-based treatment decisions and to provide optimal care for patients with breast cancer. 

The NCCN 2022 Breast Cancer Congress with Updates from the 2021 San Antonio Breast Cancer Symposium (SABCS) will provide expert insights on the current standard of care for patients with breast cancer and include the latest clinical research updates to assist clinicians in formulating breast cancer management strategies. 

Target Audience

This educational program is designed to meet the educational needs of physicians, nurse practitioners, nurses, pharmacists, physician assistants, and other health care professionals who manage patients with breast cancer.

Goal of Education & Overall Congress Objectives

The ultimate goal for NCCN continuing education is to change patient outcomes by improving the competence and performance of clinicians. The goal of the NCCN 2022 Breast Cancer Congress with Updates from the 2021 SABCS is to ensure that members of the interprofessional oncology care team, including physicians, nurse practitioners, nurses, physician assistants, pharmacists, and other relevant health care professionals, have the knowledge and skills necessary to:

• Summarize the current standards of oncology care, key updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) and clinical research updates from the 2021 San Antonio Breast Cancer Symposium, and integrate appropriate strategies into clinical practice to optimize the management of patients with breast cancer and improve patient outcomes.
• Evaluate new, emerging, and novel therapeutic agents, advances in care, and clinical trials data and apply relevant findings into the management of patients with breast cancer. 

Accreditation Statements

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
NCCN designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
NCCN designates this educational activity for a maximum of 5.75 contact hours. This program offers 3 pharmacotherapeutic contact hours for nurses. Eligible sessions are listed below:
- Neoadjuvant and Adjuvant Treatment for Breast Cancer with SABCS Updates
- Management of Metastatic Breast Cancer with SABCS Updates
- Managing Pain and Neuropathy in Breast Cancer Survivors

Pharmacists
NCCN designates this knowledge-based continuing education activity for 5.75 contact hours (0.575 CEUs) of continuing education credit. JA4008196-0000-22-013-L01-P

Physician Assistants
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Pathology Maintenance of Certification (MOC)

This activity has been registered to offer credit in the American Board of Pathology’s (ABPath) Maintenance of Certification program. Participants may earn up to 5.75 Lifelong Learning (Part II) credits.

Aggregated participant data will be shared with the commercial supporters of this activity.

American Board of Surgery Continuous Certification (CC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery's Continuous Certification Program. It is the CME activity provider's responsibility to submit learner completion information for ACCME for purpose of granting ABS credit. 

American Board of Medical Specialties Maintenance of Certification (MOC)

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, the NCCN 2022 Breast Cancer Congress has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) by the following ABMS Member Boards:

MOC Part II CME Activity

Medical Genetics and Genomics

Pathology

Radiology

Please click on the How to Claim Credit tab on the left for more information.